About Index Trending news
Analyze
Top 50 Pricing
Interface Biologics

Interface Biologics

Work at Interface Biologics? Add yourself to this profile

Interface Biologics

Develops transformative biomedical polymer technology to improve safety of med device. Focused on anti-thrombogenic additives and combo drug delivery devices.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Venture capital (Series B)
Venture capital
$1,000,000
Employees

Unknown size

Locations
HQ
Headquarters
Venture capital (Series B)
sys-con

Interface Biologics Announces Series B Financing Round With DSM and BDC Capital